Axitinib induces paradoxical erythropoietin synthesis in metastatic renal cell carcinoma.
Alexandre
Ingrid
I
Billemont
Bertrand
B
Meric
Jean Baptiste
JB
Richard
Stephane
S
Rixe
Olivier
O
D000970:Antineoplastic Agents / Q000494:pharmacology*; D000077784:Axitinib; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D004921:Erythropoietin / Q000096:biosynthesis*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D007191:Indazoles / Q000494:pharmacology*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*
D000970:Antineoplastic Agents; D007093:Imidazoles; D007191:Indazoles; D004921:Erythropoietin; D000077784:Axitinib; D011505:Protein-Tyrosine Kinases